Sven Tyge Langkjer

  1. 2020
  2. Published

    Prediction of fulvestrant efficacy in patients with advanced breast cancer : retrospective-prospective evaluation of the predictive potential of a multigene expression assay. / Christensen, Troels Dreier; Buhl, Anna Sofie Kappel; Christensen, Ib Jarle; Buhl, Ida Kappel; Balslev, Eva; Knoop, Ann S; Danø, Hella; Glavicic, Vesna; Luczak, Adam; Langkjer, Sven Tyge; Linnet, Søren; Jakobsen, Erik Hugger; Bogovic, Jurij; Ejlertsen, Bent; Rasmussen, Annie; Hansen, Anker; Knudsen, Steen; Jensen, Peter Buhl; Nielsen, Dorte.

    In: Breast Cancer, Vol. 27, No. 2, 03.2020, p. 266-276.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  3. Published

    Isoflavoner som behandlingsmulighed ved østrogenmangel. / Lambert, Max Norman Tandrup; Langkjer, Sven Tyge; Jeppesen, Per Bendix.

    In: Ugeskrift for Læger , Vol. 182, V11190643, 2020.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  4. 2019
  5. Published

    The NAME trial : A direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer. / Langkjer, Sven Tyge; Kenholm, Julia; Jensen, Jeanette Dupont; Wedervang, Kim; Brixen, Annette Torbøl; Grunnet, Mie; Stenbygaard, Lars; Gilje, Bjørnar; Danø, Hella; Glavicic, Vesna; Jacobsen, Erik Hugger; Brems-Eskildsen, Anne Sofie; Kruse, Helle Lemvig; Dongsgaard, Trine; Neimann, Jeppe; Geisler, Jürgen.

    In: Future Oncology, Vol. 15, No. 22, 08.2019, p. 2561-2569.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  6. Published

    Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer : longitudinal analyses from the randomized phase III ExteNET trial. / Delaloge, S.; Cella, D.; Ye, Y.; Buyse, M.; Chan, A.; Barrios, C. H.; Holmes, F. A.; Mansi, J.; Iwata, H.; Ejlertsen, B.; Moy, B.; Chia, S. K.L.; Gnant, M.; Smichkoska, S.; Ciceniene, A.; Martinez, N.; Filipović, S.; Ben-Baruch, N. E.; Joy, A. A.; Langkjer, S. T.; Senecal, F.; de Boer, R. H.; Moran, S.; Yao, B.; Bryce, R.; Auerbach, A.; Fallowfield, L.; Martin, M.

    In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, No. 4, 04.2019, p. 567-574.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  7. Published

    Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients : The PENELOPE Project. / Cazzaniga, Marina E.; Munzone, Elisabetta; Bocci, Guido; Afonso, Noémia; Gomez, Patricia; Langkjer, Sven; Petru, Edgar; Pivot, Xavier; Sánchez Rovira, Pedro; Wysocki, Piotr; Torri, Valter.

    In: Advances in Therapy, Vol. 36, No. 2, 02.2019, p. 381-406.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  8. Published

    Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients. / Brems-Eskildsen, Anne Sofie; Kristoffersen, Kristina Bak; Linnet, Søren; Lörincz, Tamás; Langkjer, Sven Tyge.

    In: Acta Oncologica, Vol. 58, No. 1, 2019, p. 119-121.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debateResearchpeer-review

  9. 2018
  10. Published

    Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study. / Buhl, Anna Sofie Kappel; Christensen, Troels Dreier; Christensen, Ib Jarle; Nelausen, Knud Mejer; Balslev, Eva; Knoop, Ann Søegaard; Brix, Eva Harder; Svensson, Else; Glavicic, Vesna; Luczak, Adam; Langkjer, Sven Tyge; Linnet, Søren; Jakobsen, Erik Hugger; Bogovic, Jurij; Ejlertsen, Bent; Rasmussen, Annie; Hansen, Anker; Knudsen, Steen; Nielsen, Dorte; Jensen, Peter Buhl.

    In: Breast Cancer Research and Treatment, Vol. 172, No. 2, 11.2018, p. 391-400.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  11. Published

    Carboplatin-regime som behandlingsmulighed til senstadie brystkræft. / Rosvig, Lena Hedegaard; Jensen, Anders Bonde; Langkjer, Sven Tyge; Knoop, Ann.

    In: Best Practice Oncology, 06.2018.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearch

  12. Published

    Palliative treatment with carboplatin as late line therapy to patients with metastatic breast cancer. / Rosvig, Lena H; Langkjer, Sven T; Knoop, Ann; Jensen, Anders B.

    In: Acta Oncologica, Vol. 57, No. 1, 01.2018, p. 156-159.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  13. 2017
  14. Published

    Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. / Martin, Miguel; Holmes, Frankie A; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Chia, Stephen K L; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; Tomašević, Zorica; Denduluri, Neelima; Šeparović, Robert; Gokmen, Erhan; Bashford, Anna; Ruiz Borrego, Manuel; Kim, Sung-Bae; Jakobsen, Erik Hugger; Ciceniene, Audrone; Inoue, Kenichi; Overkamp, Friedrich; Heijns, Joan B; Armstrong, Anne C; Link, John S; Joy, Anil Abraham; Bryce, Richard; Wong, Alvin; Moran, Susan; Yao, Bin; Xu, Feng; Auerbach, Alan; Buyse, Marc; Chan, Arlene; Langkjer, Sven Tyge (Member of author collaboration); ExteNET Study Group (Sven Tyge Langkjer; member).

    In: The Lancet Oncology, Vol. 18, No. 12, 12.2017, p. 1688-1700.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  15. Published

    Små hyppige doser oral kemoterapi er effektivt mod tilbagefald af brystkræft. / Langkjer, Sven Tyge.

    In: DBO-Bladet, No. 50, 02.2017, p. 18-19.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearch

  16. 2016
  17. Published

    Cryopreservation of Circulating Tumor Cells for Enumeration and Characterization. / Nejlund, Sarah; Smith, Julie; Kraan, Jaco; Stender, Henrik; Van, Mai N; Langkjer, Sven T; Nielsen, Mikkel T; Sölétormos, György; Hillig, Thore.

    In: Biopreservation and Biobanking, Vol. 14, No. 4, 08.2016, p. 330-337.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  18. 2015
  19. Published

    Resistensudvikling overfor trasuzumab (Herceptin) behandling hos kvinder med HER-2 positiv metastastisk brystkræft. / Langkjer, Sven Tyge.

    In: BestPractice Onkologi, 2015, p. 22-25.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  20. 2014
  21. Published

    Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer. / Kamby, Claus; Tarp, Simon; Mellemgaard, Anders; Christensen, Robin; Cold, Søren; Eiken, Pia; Jakobsen, Erik Hugger; Langkilde, Niels-Christian; Langkjer, Sven Tyge; Ottesen, Svend Saalbach; Laursen, Torben; Pedersen, Anita Gorm; Stenbygaard, Lars Eric; Vestlev, Peter Michael.

    In: Ugeskrift for Laeger, Vol. 2014;176:V08130525, 17.02.2014.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  22. 2011
  23. Published

    Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study. / Andersson, Michael; Lidbrink, Elisabeth; Bjerre, Karsten; Wist, Erik; Enevoldsen, Kristin; Jensen, Anders B; Karlsson, Per W.; Tange, Ulla Brix; Sørensen, Peter G; Møller, Susanne; Bergh, Jonas; Langkjer, Sven T.

    In: Journal of Clinical Oncology, Vol. 29, No. 3, 20.01.2011, p. 264-71.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  24. 2009
  25. Published

    Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting. / Sørensen, Patricia Diana; Jakobsen, Erik Hugger; Langkjer, Sven Tyge; Bokmand, Susanne; Østergaard, Birthe; Olsen, Dorte Aalund; Madsen, Jonna Skov; Brandslund, Ivan.

    In: Clinical Chemistry and Laboratory Medicine, Vol. 47, No. 9, 2009, p. 1117-23.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  26. 2004
  27. Published

    Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403). / Ejlertsen, Bent Laursen; Mouridsen, Henning T; Langkjer, Sven T; Andersen, Jørn; Sjöström, Johanna; Kjaer, Mogens.

    In: Journal of Clinical Oncology, Vol. 22, No. 12, 15.06.2004, p. 2313-20.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  28. 2001
  29. Published

    Pretreatment leukemia cell drug resistance is correlated to clinical outcome in acute leukaemia. / Nørgaard, Jan M.; Langkjer, Sven Tyge; Palshof, Torben; Pedersen, B.; Hokland, P.

    In: European Journal of Haematology, Vol. 66, No. 3, 03.2001, p. 160-167.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  30. 1998
  31. Published

    MDR1 gene expression and drug resistance of AML cells. / Nørgaard, J M; Bukh, A; Langkjer, S T; Clausen, N; Palshof, T; Hokland, P.

    In: British Journal of Haematology, Vol. 100, No. 3, 03.1998, p. 534-40.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  32. 1996
  33. Published

    Relation of blast cell survival and proliferation to chemotherapy resistance in AML. / Nørgaard, J M; Langkjer, S T; Palshof, T; Clausen, N; Pedersen, B; Hokland, P.

    In: British Journal of Haematology, Vol. 93, No. 4, 06.1996, p. 888-97.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  34. 1993
  35. Published

    Synergistic and antagonistic effects of myeloid growth factors on in vitro cellular killing by cytotoxic drugs. / Nørgaard, J M; Langkjer, S T; Ellegaard, J; Palshof, T; Clausen, N; Hokland, P.

    In: Leukemia Research, Vol. 17, No. 8, 08.1993, p. 689-94.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review